These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4310180)

  • 41. Interferons: therapeutic prospects.
    Finter NB
    Mod Trends Med Virol; 1970; 2(0):262-83. PubMed ID: 4950660
    [No Abstract]   [Full Text] [Related]  

  • 42. Chemotherapy of virus diseases.
    Diana GD; Pancic F
    Angew Chem Int Ed Engl; 1976 Jul; 15(7):410-6. PubMed ID: 182044
    [No Abstract]   [Full Text] [Related]  

  • 43. Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyriboinosinic-polyribocytidylic acid and tilorone hydrochloride on viral pathogenesis.
    Stringfellow DA; Overall JC; Glasgow LA
    J Infect Dis; 1974 Nov; 130(5):470-80. PubMed ID: 4371528
    [No Abstract]   [Full Text] [Related]  

  • 44. CIRCULATING INTERFERON IN MICE AFTER INTRAVENOUS INJECTION OF VIRUS.
    BARON S; BUCKLER CE
    Science; 1963 Sep; 141(3585):1061-3. PubMed ID: 14043352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nucleic acid-induced resistance to viral infection.
    Takano K; Warren J; Jensen KE; Neal AL
    J Bacteriol; 1965 Dec; 90(6):1542-7. PubMed ID: 4285332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of leukocyte interferon for the prevention and treatment of several viral infections].
    Ermol'eva ZV; Furer NM
    Klin Med (Mosk); 1970 Apr; 48(4):40-50. PubMed ID: 4316630
    [No Abstract]   [Full Text] [Related]  

  • 47. INTERFERON IN HUMAN SERUM DURING CLINICAL VIRAL INFECTIONS.
    WHEELOCK EF; SIBLEY WA
    Lancet; 1964 Aug; 2(7356):382-5. PubMed ID: 14173626
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of 6-azauridine and 5-iododeoxyuridine in the treatment of experimental viral infections.
    Steffenhagen KA; Easterday BC; Galasso GJ
    J Infect Dis; 1976 Jun; 133(6):603-12. PubMed ID: 180189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of herpes simplex virus by synthetic double-stranded RNA (polyriboadenylic and polyribouridylic acids and polyriboinosinic and polyribocytidylic acids).
    Hamilton LD; Babcock VI; Southam CM
    Proc Natl Acad Sci U S A; 1969 Nov; 64(3):878-83. PubMed ID: 4313333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of dermatoses of viral and non-viral etiology with interferon].
    Borzov MV; Kuznetsov VP; Lobanovskiĭ GI
    Vrach Delo; 1974; 4():149-51. PubMed ID: 4831848
    [No Abstract]   [Full Text] [Related]  

  • 51. RECENT ADVANCES IN THE DIAGNOSIS AND TREATMENT OF VIRAL DISEASES OF THE SKIN.
    ARTENSTEIN MS; DEMIS DJ
    N Engl J Med; 1964 May; 270():1101-11. PubMed ID: 14121491
    [No Abstract]   [Full Text] [Related]  

  • 52. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review.
    Akram M; Tahir IM; Shah SMA; Mahmood Z; Altaf A; Ahmad K; Munir N; Daniyal M; Nasir S; Mehboob H
    Phytother Res; 2018 May; 32(5):811-822. PubMed ID: 29356205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [What is guaranteed in the chemotherapy of virus diseases?].
    Eggers HJ
    Internist (Berl); 1973 Dec; 14(12):618-20. PubMed ID: 4593008
    [No Abstract]   [Full Text] [Related]  

  • 54. Beta-androstenes and resistance to viral and bacterial infections.
    Loria RM
    Neuroimmunomodulation; 2009; 16(2):88-95. PubMed ID: 19212128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amelioration of friend virus leukemia by sequential administration of viral and nonviral interferon inducers.
    Barker AD; Rheins MS; Wilson HE
    Proc Soc Exp Biol Med; 1971 Jul; 137(3):981-7. PubMed ID: 5105377
    [No Abstract]   [Full Text] [Related]  

  • 56. Activity of FCE 20696, a new synthetic immunomodulator, in models of viral and bacterial pathology.
    Verini MA; Ungheri D
    Immunopharmacology; 1989; 17(3):157-65. PubMed ID: 2475454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of anti-lymphoid sera on viral infections.
    Hirsch MS; Murphy FA
    Lancet; 1968 Jul; 2(7558):37-40. PubMed ID: 4172696
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of a mixed viral infection on the development of neoplasms induced by oncogenic viruses].
    Merekalova ZI; Iakovleva LS; Mazurenko NP; Orekhova NM
    Vopr Virusol; 1988; 33(4):424-8. PubMed ID: 2848364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Poly I:C, an inducer of interferon and interference against virus infections.
    Field AK; Tytell AA; Piperno E; Lampson GP; Nemes MM; Hilleman MR
    Medicine (Baltimore); 1972 May; 51(3):169-74. PubMed ID: 4336643
    [No Abstract]   [Full Text] [Related]  

  • 60. Bis-basic-substituted polycyclic aromatic compounds. A new class of antiviral agents. 5. Bis-basic ethers of anthraquinone and bisalkamine esters of anthraquinonedicarboxylic acids.
    Sill AD; Andrews ER; Sweet FW; Hoffman JW; Tiernan PL; Grisar JM; Fleming RW; Mayer GD
    J Med Chem; 1974 Sep; 17(9):965-8. PubMed ID: 4369818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.